Medtronic said today that the separation of its MiniMed Diabetes unit remains on track as it advances the MiniMed Flex system ...

The US FDA has approved Medtronic’s 780G for use with rapid-acting insulin and with Abbott’s type 2 diabetes-specific sensor.

The 510(k) decision clears the device for use with ultra-rapid-acting insulins from Eli Lilly and Novo Nordisk.

Beneficiaries of Medicare and Medicare Advantage can now obtain the MiniMed 780G system combined with the Instinct sensor.

GALWAY, Ireland, Dec. 2, 2025 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the broad U.S. commercial launch of the MiniMed™ 780G system integrated ...

Medtronic (NYSE:MDT) has recalled its SonarMed Airway acoustic sensors, which are used with ventilators to provide real-time airway monitoring information to clinicians. According to the FDA’s website ...

Medtronic plc’s MDT most advanced automated insulin delivery (AID) system, MiniMed 780G, was recently recognized by the Fast Company in the Best World-Changing Idea, North America category as part of ...

MiniMed Go™ is the first and only smart MDI system that automatically integrates insulin dosing and glucose data in a single app to provide empowering insights for individuals on multiple daily ...

Abbott Laboratories is linking its continuous glucose monitoring with automated insulin delivery by entering a global partnership with health tech giant Medtronic. The pairing of Abbott's leading ...